FDA extends approval of pembrolizumab for classical Hodgkin lymphoma

Hematology / Oncology Approvals

Source: FDA Center for Drug Evaluation and Research - What's New - October 15, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news